Compare XIIIU & STLNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XIIIU | STLNW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2026 | 2020 |
| Metric | XIIIU | STLNW |
|---|---|---|
| Price | $10.40 | $0.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 62.6K | 6.6K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $502,729,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.79 |
| 52 Week Low | $10.30 | $0.02 |
| 52 Week High | $11.34 | $0.07 |
| Indicator | XIIIU | STLNW |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 42.95 |
| Support Level | N/A | $0.02 |
| Resistance Level | $10.57 | $0.05 |
| Average True Range (ATR) | 0.05 | 0.01 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 0.00 | 32.20 |
Churchill Capital Corp XIII is an emerging growth company. The purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified.
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.